From: MicroRNAs as the critical regulators of protein kinases in prostate and bladder cancers
Gene | Target | Cancer | Sample | Results | Country | Year | Study |
---|---|---|---|---|---|---|---|
Class I receptors of tyrosine kinases | |||||||
miR-133a/b | EGFR | Bladder | 2 cell lines | The miR133a and miR-133b reduced tumor growth, cell proliferation, and migration | China | 2012 | Zhou [39] |
miR-135a | EGFR | Prostate | 141 patients 2 cell lines | MiR-135a suppressed cell proliferation and migration | China | 2016 | Xu [40] |
miR-875-5p | EGFR | Prostate | 2 cell lines | The miR-875-5p promoted radiosensitivity | Italy | 2017 | Bezawy [44] |
miR-200a | EGFR | Bladder | 3 cell lines | MiR-200a downregulation promoted of EGFR translation and enhancement of anchorage-independent tumor growth | USA | 2017 | Huang [64] |
miR-133a/b | EGFR | Prostate | 2 cell lines | MiR-133 functions as a potent tumor suppressor agent, especially in androgen-independent PCa | China | 2012 | Tao [65] |
miR-4319 | Her-2 | Prostate | 40 patients 2 cell lines | Suppressed growth and chemoresistance | USA | 2018 | Lin [69] |
miR-331-3p | Her-2 | Prostate | 1 cell line | MiR-331-3p was associated with PCa progression | Australia | 2011 | Epis [73] |
miR-148a-3p | ERBB3 | Bladder | 59 patients 5 cell lines | Suppressed EMT | China | 2016 | Wang [75] |
Class V, VII, and VIII receptors of tyrosine kinases | |||||||
miR-99a | FGFR3 | Prostate | 2 cell lines | Inhibited PCa cell growth, invasion, and migration | China | 2014 | Wu [79] |
miR-100 | FGFR3 | Bladder | 4 cell lines | Hypoxia increased viability of tumor cells under stressful conditions through miR-100 suppression | UK | 2013 | Blick [84] |
miR-1-3p | TrkB | Bladder | 38 patients 5 cell lines | Inhibited the progression and invasion of BCa | China | 2018 | Gao [86] |
miR-34C | MET | Prostate | 47 patients 6 cell lines | There was an inverse correlation between MET and miR-34c expression levels | Sweden | 2013 | Hagman [95] |
miR-323a | c-Met | Bladder | 20 patients 5 cell lines | Induced apoptosis | China | 2019 | Qiu [99] |
miR-409-3p | c-Met | Bladder | 10 patients 5 cell lines | Inhibited BCa migration and invasion | China | 2013 | Xu [100] |
miR-23b/27b | EGFR, c-MET | Bladder | 58 patients 2 cell lines | Suppressed proliferation and migration of BCa cells | Japan | 2014 | Chiyomaru [101] |
miR-101 | c-Met | Bladder | 10 patients 2 cell lines | Repressed BCa invasion | China | 2013 | Hu [106] |
miR-323a-3p | MET | Bladder | 9 patients 4 cell lines | Inhibited invasion and migration of BCa cell lines | China | 2017 | Li [107] |
miR-1 | c-Met | Prostate | 3 cell lines | Repressed the proliferation | China | 2019 | Gao [108] |
Class II and X receptors of tyrosine kinases | |||||||
miR‐139 | IGF1R, AXL | Prostate | 585 patients 3 cell lines | Inhibited PCa cell migration, proliferation, and cell cycle | Canada | 2019 | Nam [113] |
miR-145 | IGFIR | Bladder | 3 cell lines | Tumor suppressor | China | 2014 | Zhu [114] |
Let-7a1 | IGF1R | Prostate | 1 cell line | Suppressed prostate tumor cell proliferation, and triggers cell cycle arrest and apoptosis | China | 2013 | Wang [118] |
Non-receptor tyrosine kinases | |||||||
miR-4723 | ABL | Prostate | 57 patients 2 cell lines | Inhibited tumor cell proliferation and invasion and induced apoptosis | USA | 2013 | Arora [121] |
miR‐20a | ABL2 | Prostate | 30 patients 5 cell lines | Inhibited migration and invasion of PCa cells | China | 2014 | Qiang [126] |
miR-3607 | SRC | Prostate | 100 patients 5 cell lines | Suppressed the tumorigenicity | USA | 2014 | Saini [130] |
miR-1 | SRC | Prostate | 139 patients 2 cell lines | There was an inverse association between miR-1 and SRC expression levels | Taiwan/USA | 2015 | Liu [137] |
miR-124 | SRC | Prostate | 4 cell lines | Inhibited PCa cell proliferation, increased sensitivity to enzalutamide, and triggered apoptosis | USA | 2015 | Shi [140] |
miR-1178-3p | SRC | Bladder | 82 patients 3 cell lines | The circFNDC3B upregulation suppressed BCa growth and metastasis via miR-1178-3p sponging | China | 2018 | Liu [143] |
miR-199a | YES1 | Prostate | 74 patients 1 cell line | Increased chemosensitivity and apoptotic cell death | China | 2017 | Chen [146] |
miR-631 | ZAP70 | Prostate | 43 patients 6 cell lines | Suppressed invasion and migration of prostate tumor cells | China | 2016 | Fu [150] |
miR-214 | PTK6 | Prostate | 5 cell lines | Reduced cell proliferation and viability in PCa | USA | 2019 | Cagle [154] |
Serine threonine kinases | |||||||
miR-27a | MAP2K4 | Prostate | 17 patients 5 cell lines | Tumor suppressor | China | 2016 | Wan [157] |
miR-136 | MAP2K4 | Prostate | 27 patients 5 cell lines | Suppressed proliferation and invasion of PCa cells | China | 2018 | Zhu [158] |
miR-1826 | MEK1 | Bladder | 19 patients 4 cell lines | Inhibited cancer cell viability and invasion, and induced apoptosis | USA | 2012 | Hirata [162] |
miR-30e | MAPK | Prostate | 57 patients 2 cell lines | Inhibited PCa cell invasion and migration | China | 2018 | Zheng [170] |